Further evaluation of transurethral laser ablation of the prostate in patients treated with anticoagulant therapy

被引:20
作者
Kingston, TE
Nonnenmacher, AK
Crowe, H
Costello, AJ
Street, A
机构
[1] St Vincents Hosp, Dept Urol, Melbourne, Vic, Australia
[2] NH&MRC Natl Ctr Hlth Program Evaluat, Melbourne, Vic, Australia
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1995年 / 65卷 / 01期
关键词
anticoagulants; haemorrhage; lasers; prostatic hypertrophy;
D O I
10.1111/j.1445-2197.1995.tb01745.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Transurethral Nd: YAG laser ablation of the prostate gland was used to treat benign prostatic hyperplasia (BPH) in 20 patients on Warfarin anticoagulant therapy, and in two patients with abnormal coagulation parameters secondary to haematologic disorders. Preliminary results for the first 10 of these patients has been reported previously. The mean pre-operative international normalized ratio (INR) was 2.6 (range 1.19 to 5.25) and the mean prostate volume was 56 cc (13.6-112 cc). All patients had significant subjective and objective indicators of prostatic obstruction and six patients were in urinary retention. Postoperative improvement in symptom score, maximum flow rate and post-void residual was noted in 82% of patients at 3 months, 89% at 6 months and 75% at 1 year. Two patients have required revision laser or transurethral resection of the prostate (TURP) for persistent obstruction, while one patient required revision TURP for intractable haematuria. Three patients developed haematuria requiring transfusion while four patients had mild haematuria requiring no intervention. Laser ablation of the prostate can be used successfully and safely to treat prostatic obstruction in patients with abnormal coagulation parameters, or in those who are fully anticoagulated. Anticoagulation can be maintained during surgery in this group unlike TURP where pre-operative reversal is necessary with reinstitution of therapy several days postoperatively. Other authors report at least a 50% blood transfusion rate in this group. Laser prostatectomy appears the more appealing surgical option in these patients.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 16 条
[1]  
ALLEN NH, 1978, BRIT MED J, V9, P1326
[2]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[3]   MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA BY TRANSURETHRAL LASER-ABLATION IN PATIENTS TREATED WITH WARFARIN ANTICOAGULATION [J].
BOLTON, DM ;
COSTELLO, AJ .
JOURNAL OF UROLOGY, 1994, 151 (01) :79-81
[4]  
Childs Stacy, 1993, Journal of Urology, V149, p467A
[5]   ND-YAG LASER ABLATION OF THE PROSTATE AS A TREATMENT FOR BENIGN PROSTATIC HYPERTROPHY [J].
COSTELLO, AJ ;
JOHNSON, DE ;
BOLTON, DM .
LASERS IN SURGERY AND MEDICINE, 1992, 12 (02) :121-124
[6]  
COSTELLO AJ, 1994, IN PRESS J UROL
[7]  
Costello Anthony J., 1993, Journal of Urology, V149, p214A
[8]  
DOLL HA, 1992, J UROLOGY, V147, P1566, DOI 10.1016/S0022-5347(17)37628-0
[9]   PATHOLOGICAL-CHANGES OCCURRING IN THE PROSTATE FOLLOWING TRANSURETHRAL LASER PROSTATECTOMY [J].
JOHNSON, DE ;
PRICE, RE ;
CROMEENS, DM .
LASERS IN SURGERY AND MEDICINE, 1992, 12 (03) :254-263
[10]   LASER PROSTATECTOMY PERFORMED WITH A RIGHT-ANGLE FIRING NEODYMIUM-YAG LASER FIBER AT 40 WATTS POWER SETTING [J].
KABALIN, JN .
JOURNAL OF UROLOGY, 1993, 150 (01) :95-99